We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Using Proteomics to Enable the Adaptive and Innate Immune Response in Vaccines against COVID-19

Featured Speaker: Moriya Tsuji, MD, PhD, Professor of Medicine at Aaron Diamond AIDS Research Center, Columbia University

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Using more predictive single cell proteomics in mouse models to understand correlative T cell potency in infectious disease vaccines

Understanding of more predictive T cell potency in mouse models important for understanding vaccine development

The challenges in pre-clinical vaccine development today that can be overcome by having potency tools and better ways to characterize human immune response

Watch the Webinar